XML 39 R23.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Segment and Geographic Information | 12 Months Ended
--- | ---
Dec. 28, 2018
Segment Reporting [Abstract] |
SEGMENT AND GEOGRAPHIC INFORMATION | The following table presents sales by customer for fiscal year 2018.
Customer |  | Medical |  | Non-Medical
Customer A |  | 22 | % |  | — | %
Customer B |  | 19 | % |  | — | %
Customer C |  | 12 | % |  | — | %
Customer D |  | — | % |  | 28 | %
All other customers |  | 47 | % |  | 72 | %
(17.) SEGMENT AND GEOGRAPHIC INFORMATION The Company organizes its business into two reportable segments: (1) Medical and (2) Non-Medical. This segment structure reflects the financial information and reports used by the Company’s management, specifically its Chief Operating Decision Maker (“CODM”), to make decisions regarding the Company’s business, including resource allocations and performance assessments. This segment structure reflects the Company’s current operating focus in compliance with ASC 280, Segment Reporting. The Company defines segment income from operations as sales less cost of sales including amortization and expenses attributable to segment-specific selling, general, administrative, research, development, engineering and other operating activities. The remaining unallocated operating and other expenses are primarily administrative corporate headquarter expenses and capital costs that are not allocated to reportable segments. Transactions between the two segments are not significant. (17.) SEGMENT AND GEOGRAPHIC INFORMATION (Continued) The following table presents sales by product line for fiscal years 2018, 2017 and 2016 (in thousands).
| 2018 |  | 2017 |  | 2016
Segment sales by product line: |  |  |  |  |
Medical |  |  |  |  |
Cardio & Vascular | $ | 585,464 |  |  | $ | 530,831 |  |  | $ | 484,891 |
Cardiac & Neuromodulation | 443,347 |  |  | 428,275 |  |  | 439,375 |
Advanced Surgical, Orthopedics & Portable Medical | 133,225 |  |  | 120,006 |  |  | 109,557 |
Total Medical | 1,162,036 |  |  | 1,079,112 |  |  | 1,033,823 |
Non-Medical | 52,976 |  |  | 56,968 |  |  | 41,679 |
Total sales | $ | 1,215,012 |  |  | $ | 1,136,080 |  |  | $ | 1,075,502 |
A significant portion of the Company’s sales for fiscal years 2018, 2017 and 2016 and accounts receivable at December 28, 2018 and December 29, 2017 were to three customers as follows:
| Sales |  | Accounts Receivable
| 2018 |  | 2017 |  | 2016 |  | December 28, 2018 |  | December 29, 2017
Customer A | 21% |  | 22% |  | 24% |  | 11% |  | 11%
Customer B | 19% |  | 20% |  | 21% |  | 18% |  | 21%
Customer C | 12% |  | 11% |  | 12% |  | 20% |  | 20%
| 52% |  | 53% |  | 57% |  | 49% |  | 52%
The following table presents income from operations for the Company’s reportable segments for fiscal years 2018, 2017 and 2016 (in thousands).
| 2018 |  | 2017 |  | 2016
Segment income from operations: |  |  |  |  |
Medical | $ | 224,893 |  |  | $ | 197,212 |  |  | $ | 170,101 |
Non-Medical | 14,697 |  |  | 11,335 |  |  | 1,513 |
Total segment income from operations | 239,590 |  |  | 208,547 |  |  | 171,614 |
Unallocated operating expenses | (84,035 | ) |  | (82,898 | ) |  | (78,691 | )
Operating income | 155,555 |  |  | 125,649 |  |  | 92,923 |
Unallocated expenses, net | (94,439 | ) |  | (76,390 | ) |  | (64,758 | )
Income before benefit for income taxes | $ | 61,116 |  |  | $ | 49,259 |  |  | $ | 28,165 |
The following table presents depreciation and amortization expense for the Company’s reportable segments for fiscal years 2018, 2017 and 2016 (in thousands).
| 2018 |  | 2017 |  | 2016
Segment depreciation and amortization: |  |  |  |  |
Medical | $ | 71,922 |  |  | $ | 72,314 |  |  | $ | 65,528 |
Non-Medical | 1,364 |  |  | 2,675 |  |  | 2,346 |
Total depreciation and amortization included in segment income from operations | 73,286 |  |  | 74,989 |  |  | 67,874 |
Unallocated depreciation and amortization | 8,252 |  |  | 6,194 |  |  | 4,994 |
Total depreciation and amortization | $ | 81,538 |  |  | $ | 81,183 |  |  | $ | 72,868 |
(17.) SEGMENT AND GEOGRAPHIC INFORMATION (Continued) The following table presents total assets for the Company’s reportable segments as of December 28, 2018 and December 29, 2017 (in thousands).
| December 28, 2018 |  | December 29, 2017
Identifiable assets: |  |  |
Medical(1) | $ | 2,186,565 |  |  | $ | 2,687,227 |
Non-Medical | 53,812 |  |  | 54,071 |
Total reportable segments | 2,240,377 |  |  | 2,741,298 |
Unallocated assets | 86,304 |  |  | 107,047 |
Total assets | $ | 2,326,681 |  |  | $ | 2,848,345 |
__________
(1) | Medical segment identifiable assets at December 29, 2017 includes $451.4 million of assets held sale.
The following table presents capital expenditures for the Company’s reportable segments for fiscal years 2018, 2017 and 2016 (in thousands).
| 2018 |  | 2017 |  | 2016
Expenditures for tangible long-lived assets: |  |  |  |  |
Medical | $ | 34,615 |  |  | $ | 20,896 |  |  | $ | 27,014 |
Non-Medical | 573 |  |  | 661 |  |  | 1,451 |
Total reportable segments | 35,188 |  |  | 21,557 |  |  | 28,465 |
Unallocated long-lived tangible assets | 6,110 |  |  | 8,783 |  |  | 8,251 |
Total expenditures | $ | 41,298 |  |  | $ | 30,340 |  |  | $ | 36,716 |
Geographic Area Information The following table presents sales by significant country for fiscal years 2018, 2017 and 2016. In these tables, sales are allocated based on where the products are shipped (in thousands).
| 2018 |  | 2017 |  | 2016
Sales by geographic area: |  |  |  |  |
United States | $ | 687,259 |  |  | $ | 662,133 |  |  | $ | 625,670 |
Non-Domestic locations: |  |  |  |  |
Puerto Rico | 146,500 |  |  | 140,184 |  |  | 162,343 |
Costa Rica | 62,044 |  |  | 55,364 |  |  | 53,501 |
Rest of world | 319,209 |  |  | 278,399 |  |  | 233,988 |
Total sales | $ | 1,215,012 |  |  | $ | 1,136,080 |  |  | $ | 1,075,502 |
The following table presents PP&E by geographic area as of December 28, 2018 and December 29, 2017. In these tables, PP&E is aggregated based on the physical location of the tangible long-lived assets (in thousands).
| December 28, 2018 |  | December 29, 2017
Long-lived tangible assets by geographic area: |  |  |
United States | $ | 151,851 |  |  | $ | 157,808 |
Mexico | 34,606 |  |  | 28,985 |
Ireland | 32,190 |  |  | 33,992 |
Rest of world | 12,622 |  |  | 14,395 |
Total | $ | 231,269 |  |  | $ | 235,180 |
(17.) SEGMENT AND GEOGRAPHIC INFORMATION (Continued) Disaggregation of Revenue by Segment In general, the Company's business segmentation is aligned according to the nature and economic characteristics of its products and customer relationships and provides meaningful disaggregation of each business segment's results of operations. Additionally, the tables below disaggregate the Company’s revenues based upon significant customers, which are defined as any customer who individually represents 10% or more of a segment’s total revenues, and ship to country, which is defined as any country where 10% or more of a segment’s total revenues are shipped to. The Company believes that these categories best depict how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors. The following table presents sales by customer for fiscal year 2018.
Customer |  | Medical |  | Non-Medical
Customer A |  | 22 | % |  | — | %
Customer B |  | 19 | % |  | — | %
Customer C |  | 12 | % |  | — | %
Customer D |  | — | % |  | 28 | %
All other customers |  | 47 | % |  | 72 | %
The following table presents revenues by ship to country for fiscal year 2018.
Ship to Location |  | Medical |  | Non-Medical
United States |  | 56% |  | 66%
Puerto Rico |  | 13% |  | —%
Canada |  | —% |  | 11%
All other Countries |  | 31% |  | 23%

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration